Dr. B

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded semaglutide (low dose)Compounded · not FDA-approved
• Compounded tirzepatide (low dose)Compounded · not FDA-approved

What they publish

Dr. B publishes 0 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

Pricing was not published on the page we captured

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• States on its own page that clinical studies have not studied the safety or efficacy of personalised compounded medications used in microdosing. That is a company undercutting its own sales pitch with an accurate caveat, and it is rare enough to be worth naming.
• Positions microdosing around reducing side effects such as nausea, which is a plausible rationale even without trial evidence behind the specific protocol.
• Compounded only.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Take the company's own caveat seriously — microdosing is not an evidence-backed regimen.
• Establish the monthly cost, which was not published.
• Ask which pharmacy compounds the product and whether it is 503A or 503B.

Frequently asked